sodium tetradecyl sulfate has been researched along with polidocanol in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (6.85) | 18.7374 |
1990's | 9 (12.33) | 18.2507 |
2000's | 19 (26.03) | 29.6817 |
2010's | 30 (41.10) | 24.3611 |
2020's | 10 (13.70) | 2.80 |
Authors | Studies |
---|---|
Nakao, A; Nonami, T; Suzuki, N; Takagi, H | 1 |
Bhargava, DK; Dasarathy, S; Dogra, R; Sharma, MP; Singh, B | 1 |
Carlin, MC; Ratz, JL | 1 |
Cappellari, L; Fogli, L; Gorini, P; Gullini, S; Morsiani, E; Rimondi, AP | 1 |
Bennett, RG; Cavender, PA; Goldman, MP; Kaplan, RP; Oki, LN; Strick, RA | 1 |
Hammerschmidt, DE; Hutton, SW; Jacob, HS; Silvis, SE; Stroncek, DF; Vercellotti, GM | 1 |
Brooks, WS | 1 |
Conrad, P; Malouf, GM; Stacey, MC | 1 |
Fardy, JM; Laupacis, A | 1 |
Weiss, RA | 1 |
Rotter, SM; Weiss, RA | 1 |
Farber, B; Sadick, NS | 1 |
Klein, RF; Sadick, NS; Senterfit, LB | 1 |
Labas, P; Smolen, V | 1 |
Fisher, DA | 1 |
Marrocco-Trischitta, MM; Nicodemi, EM; Stillo, F | 1 |
Ananthakrishnan, N; Kate, V; Ravi, M | 1 |
Cavezzi, A; Frullini, A | 1 |
Goldman, MP | 1 |
Cambal, M; Fillo, J; Labas, P; Ohradka, B; Reis, R | 1 |
Belikov, LN; Gorbachev, IuI; Rodionov, OA; Rodionova, IG; Sukovatykh, BS; Sukovatykh, MB | 1 |
Goldman, MP; Rao, J | 1 |
Guex, JJ | 2 |
Goldman, MP; Rao, J; Wildemore, JK | 1 |
Smith, PC | 1 |
Bihari, I | 1 |
Earnshaw, JJ; O'Hare, JL | 1 |
Aysan, E; Basak, F; Kinaci, E; Tutuncu, H | 1 |
Connor, DE; Exner, T; Joseph, JE; Ma, DD; Parsi, K | 2 |
Connor, DE; Exner, T; Herbert, A; Joseph, JE; Ma, DDF; Parsi, K | 1 |
Khubulaeva, GG; Sazonov, AA; Sazonov, AB | 1 |
Exner, T; Joseph, JE; Low, J; Ma, DD; Parsi, K | 1 |
Breu, FX; Otto, J; Pannier, F; Rabe, E; Schliephake, D | 1 |
Duffy, DM | 1 |
Kiripolsky, MG | 1 |
Exner, T; Joseph, JE; Ma, DD; Parsi, K | 1 |
Exner, T; Fung Ma, DD; Joseph, JE; Low, J; Parsi, K | 1 |
Maxwell, H; Schwartz, L | 1 |
Norris, A; Rathbun, S; Stoner, J | 1 |
Abbott, C; Brockbank, K; Gough, MJ; Homer-Vanniasinkam, S; Ikponmwosa, A; McAree, B | 1 |
Connor, DE; Joseph, JE; Low, J; Ma, DD; Parsi, K; Pilotelle, A | 1 |
Barsotti, MC; Burchielli, S; Di Stefano, R; Duranti, E; Frullini, A; Santoni, T | 1 |
Fischman, AM; Patel, A; Saad, WE | 1 |
Breu, FX; Cavezzi, A; Coleridge Smith, P; Frullini, A; Gillet, JL; Guex, JJ; Hamel-Desnos, C; Kern, P; Pannier, F; Partsch, B; Rabe, E; Ramelet, AA; Tessari, L | 1 |
Davies, AH; Shepherd, A; Smith, PC; Willenberg, T | 1 |
Behnia, M; Cameron, E; Chen, T; Connor, DE; Parsi, K | 1 |
Behnia, M; Connor, DE; Parsi, K; Valenzuela, GC; Wong, K | 1 |
Chaer, RA; Dillavou, ED; Hager, ES; Hirsch, SA; Kiguchi, MM; Winger, DG | 1 |
Behnia, M; Chen, T; Connor, DE; Parsi, K; Wong, K | 1 |
Parsi, K | 1 |
Ghaznavi, AM; Nakamura, M; Tepper, D | 1 |
Connor, DE; Cooley-Andrade, O; Goh, WX; Ma, DD; Parsi, K | 2 |
Aronniemi, J; Castrén, E; Klockars, T; Lappalainen, K; Pekkola, J; Pitkäranta, A; Salminen, P; Vuola, P | 1 |
Behnia, M; Connor, D; Fakhim, B; Parsi, K; Tan, L; Wong, K | 1 |
Bush, P; Bush, R | 2 |
Whiteley, MS | 1 |
Kobayakawa, M; Ohnishi, S; Suzuki, H | 1 |
Blaise, S; Cracowski, JL; Khouri, C; Roselli, A; Roustit, M | 1 |
Connor, D; Li, T; Parsi, K | 1 |
Bai, T; Fan, Y; Jiang, W; Li, Y; Liu, J; Liu, Y; Yu, C | 1 |
Markovic, JN; Nag, U; Shortell, CK | 1 |
Czaja, J; Hobot, J; Simka, M; Skuła, M | 1 |
Andrade, OC; Connor, DE; Parsi, K; Wong, K | 1 |
Bester, L; Connor, D; Gracé, J; Parsi, K; Rogan, C | 1 |
Avrahami, M; Avrahami, R; Elias, S; Kolvenbach, R; Shufutinsky, N; Silverberg, D; Sivak, G; Tal, M | 1 |
Aboul-Fettouh, N; Mays, S; Nguyen, T; Silapunt, S | 1 |
Nguyen, CN; Nguyen, QD; Silapunt, S | 1 |
Cao, J; Liu, J; Wang, Z; Zhang, X | 1 |
12 review(s) available for sodium tetradecyl sulfate and polidocanol
Article | Year |
---|---|
A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices.
Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Odds Ratio; Polidocanol; Polyethylene Glycols; Publication Bias; Risk Factors; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Treatment Outcome | 1994 |
Foam sclerotherapy: an overview of use for primary venous insufficiency.
Topics: Drug Combinations; Follow-Up Studies; Humans; Injections, Intravenous; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Time Factors; Treatment Outcome; Venous Insufficiency | 2005 |
Complications and side-effects of foam sclerotherapy.
Topics: Cough; Detergents; Dosage Forms; Embolism, Air; Humans; Intracranial Embolism; Ischemic Attack, Transient; Microbubbles; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Thrombosis; Ultrasonography, Interventional; Varicose Veins; Vision Disorders | 2009 |
Sclerosants: a comparative review.
Topics: Clinical Trials as Topic; Detergents; Drug Approval; Drug Interactions; Drug Storage; Humans; Microbubbles; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; United States; United States Food and Drug Administration; Varicose Veins | 2010 |
Sclerotherapy for lower limb telangiectasias.
Topics: Heparin; Humans; Leg; Patient Satisfaction; Polidocanol; Polyethylene Glycols; Randomized Controlled Trials as Topic; Sclerosing Solutions; Sclerotherapy; Sodium Chloride; Sodium Tetradecyl Sulfate; Telangiectasis | 2011 |
Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Child; Child, Preschool; Endovascular Procedures; Female; Glycerol; Humans; Infant; Male; Middle Aged; Polidocanol; Polyethylene Glycols; Postoperative Complications; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Stockings, Compression; Treatment Outcome; Ultrasonography, Interventional; Varicose Veins; Vascular Diseases; Veins | 2012 |
Balloon-occluded retrograde transvenous obliteration of gastric varices.
Topics: Balloon Occlusion; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Oleic Acids; Polidocanol; Polyethylene Glycols; Radiography, Interventional; Recurrence; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Stomach; Tomography, X-Ray Computed; Vinblastine | 2012 |
Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
Topics: Embolism; Female; Humans; Male; MEDLINE; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Telangiectasis; Varicose Veins; Vision Disorders | 2013 |
Interaction of detergent sclerosants with cell membranes.
Topics: Animals; Cell Membrane; Humans; Lipid Bilayers; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Surface Tension | 2015 |
Recent development of balloon-occluded retrograde transvenous obliteration.
Topics: Balloon Occlusion; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis; Oleic Acids; Polidocanol; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2019 |
A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
Topics: Drug Compounding; Drug Stability; Gases; Half-Life; Humans; Injections, Intravenous; Polidocanol; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Surface-Active Agents; Temperature; Time Factors; Varicose Veins | 2020 |
A systematic review and network meta-analysis of the effectiveness of sclerotherapy for venous malformation.
Topics: Bleomycin; Ethanol; Humans; Network Meta-Analysis; Polidocanol; Sclerosing Solutions; Sclerotherapy; Sodium Morrhuate; Sodium Tetradecyl Sulfate; Treatment Outcome; Vascular Malformations | 2023 |
9 trial(s) available for sodium tetradecyl sulfate and polidocanol
Article | Year |
---|---|
Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents.
Topics: Adolescent; Adult; Aged; Child; Drug Evaluation; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Polidocanol; Polyethylene Glycols; Recurrence; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Survival Analysis | 1992 |
Treatment of telangiectasia: comparison of sclerosing agents.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Heparin; Humans; Middle Aged; Polidocanol; Polyethylene Glycols; Saline Solution, Hypertonic; Sclerosing Solutions; Sodium Chloride; Sodium Tetradecyl Sulfate; Telangiectasis | 1987 |
The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
Topics: Anesthetics, Local; Double-Blind Method; Humans; Hypertonic Solutions; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Telangiectasis; Varicose Veins | 1995 |
Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
Topics: Adult; Esophageal and Gastric Varices; Female; Humans; Male; Polidocanol; Polyethylene Glycols; Prospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate | 2001 |
Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol.
Topics: Double-Blind Method; Humans; Leg; Polidocanol; Polyethylene Glycols; Prospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Telangiectasis; Treatment Outcome; Varicose Veins | 2002 |
Long term results of compression sclerotherapy.
Topics: Bandages; Follow-Up Studies; Humans; Polidocanol; Polyethylene Glycols; Recurrence; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Varicose Veins | 2003 |
Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Topics: Double-Blind Method; Female; Humans; Male; Patient Satisfaction; Polidocanol; Polyethylene Glycols; Prospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Telangiectasis; Treatment Outcome; Varicose Veins | 2005 |
Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
Topics: Adolescent; Adult; Aged; Double-Blind Method; Female; Humans; Isotonic Solutions; Male; Middle Aged; Patient Satisfaction; Photography; Placebos; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Chloride; Sodium Tetradecyl Sulfate; Telangiectasis; Treatment Outcome; Veins; Young Adult | 2010 |
Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
Topics: Adult; Aged; Blood Cell Count; Female; Fibrin Fibrinogen Degradation Products; Humans; Male; Middle Aged; Partial Thromboplastin Time; Polidocanol; Polyethylene Glycols; Saphenous Vein; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Thrombophilia; Ultrasonography, Doppler, Duplex; Ultrasonography, Interventional | 2014 |
52 other study(ies) available for sodium tetradecyl sulfate and polidocanol
Article | Year |
---|---|
Experimental study on the effects of sclerosants for esophageal varices on blood coagulation, fibrinolysis and systemic hemodynamics.
Topics: Animals; Blood Coagulation; Dogs; Endothelium, Vascular; Esophageal and Gastric Varices; Fibrinolysis; Hemodynamics; Oleic Acids; Platelet Count; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Thrombin; Thrombophlebitis | 1992 |
Effect of intravenous and intraperivenous injections of sclerosants (sodium tetradecyl sulfate and hydroxy polyethoxy dodecan) on the rat femoral vein.
Topics: Animals; Esophageal and Gastric Varices; Female; Femoral Vein; Injections; Injections, Intravenous; Male; Polidocanol; Polyethylene Glycols; Rats; Rats, Inbred Strains; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 1987 |
Sclerosing agents in the treatment of telangiectasia. Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model.
Topics: Animals; Ear; Fatty Alcohols; Injections, Intravenous; Necrosis; Polidocanol; Polyethylene Glycols; Rabbits; Saline Solution, Hypertonic; Sodium Chloride; Sodium Tetradecyl Sulfate; Telangiectasis; Veins | 1987 |
Sodium morrhuate stimulates granulocytes and damages erythrocytes and endothelial cells: probable mechanism of an adverse reaction during sclerotherapy.
Topics: Blood Coagulation; Cell Aggregation; Cell Survival; Cells, Cultured; Complement Activation; Endothelium; Erythrocytes; Fatty Acids; Granulocytes; Hemolysis; Humans; Lymphocyte Activation; Neutrophils; Oleic Acids; Platelet Aggregation; Polidocanol; Polyethylene Glycols; Sodium Morrhuate; Sodium Tetradecyl Sulfate | 1985 |
Variceal sclerosing agents.
Topics: Animals; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Oleic Acids; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Morrhuate; Sodium Tetradecyl Sulfate | 1984 |
Polidocanol: the perfect "solution".
Topics: Humans; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Varicose Veins | 1994 |
Human saphenous vein in vitro model for studying the action of sclerosing solutions.
Topics: Endothelium, Vascular; Humans; Necrosis; Polidocanol; Polyethylene Glycols; Saline Solution, Hypertonic; Saphenous Vein; Sclerosing Solutions; Sodium Chloride; Sodium Tetradecyl Sulfate; Tunica Intima | 1993 |
A microbiologic study of diluted sclerotherapy solutions.
Topics: Bacteria; Drug Contamination; Fungi; Iodides; Polidocanol; Polyethylene Glycols; Saline Solution, Hypertonic; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 1993 |
The intrinsic antimicrobial activity of selected sclerosing agents in sclerotherapy.
Topics: Anti-Bacterial Agents; Detergents; Drug Synergism; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Staphylococcus aureus | 1996 |
[Sclerosing agents in clinical practice].
Topics: Adolescent; Adult; Aged; Female; Humans; Male; Middle Aged; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Varicose Veins | 1996 |
Regarding extensive tissue necrosis following high concentration sclerotherapy for varicose veins.
Topics: Drug Approval; Humans; Necrosis; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; United States; United States Food and Drug Administration; Varicose Veins | 2000 |
Sclerotherapy for venous malformations of the glans penis.
Topics: Adolescent; Adult; Child; Hemoglobinuria; Humans; Male; Penis; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Ultrasonography; Veins | 2001 |
Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Topics: Humans; Polidocanol; Polyethylene Glycols; Retrospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Telangiectasis; Treatment Outcome; Varicose Veins | 2002 |
[Sclerotherapy of small pelvis varicosis].
Topics: Adult; Female; Humans; Male; Pelvis; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Varicose Veins | 2004 |
Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
Topics: Dosage Forms; Humans; Plastics; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Silicones; Sodium Tetradecyl Sulfate; Stainless Steel; Varicose Veins | 2005 |
Chronic venous disease treated by ultrasound guided foam sclerotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Humans; Male; Middle Aged; Polidocanol; Polyethylene Glycols; Recurrence; Saphenous Vein; Sclerosing Solutions; Sclerotherapy; Severity of Illness Index; Sodium Tetradecyl Sulfate; Treatment Outcome; Ultrasonography, Interventional; Varicose Veins; Vascular Patency | 2006 |
[Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections].
Topics: Adult; Aged; Aged, 80 and over; Contraindications; Disease Progression; Female; Humans; Injections, Intravenous; Lower Extremity; Male; Middle Aged; Polidocanol; Polyethylene Glycols; Retreatment; Retrospective Studies; Saphenous Vein; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Time Factors; Treatment Outcome; Ultrasonography; Varicose Veins | 2007 |
The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland.
Topics: Cerebrovascular Disorders; Health Care Surveys; Humans; Ireland; Patient Selection; Polidocanol; Polyethylene Glycols; Practice Patterns, Physicians'; Sclerosing Solutions; Sclerotherapy; Societies, Medical; Sodium Tetradecyl Sulfate; Stockings, Compression; Surveys and Questionnaires; United Kingdom; Varicose Veins; Venous Thrombosis; Vision Disorders | 2007 |
Efficacy of local sclerosing agents on hemostasis of hepatic bleeding.
Topics: Animals; Female; Hemorrhage; Hemostasis; Liver Diseases; Polidocanol; Polyethylene Glycols; Rats; Rats, Wistar; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2007 |
In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
Topics: Blood Coagulation; Blood Coagulation Tests; Dose-Response Relationship, Drug; Factor Xa; Flow Cytometry; Hemostasis; Humans; In Vitro Techniques; Particle Size; Platelet Aggregation; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Surface-Active Agents; Time Factors; Whole Blood Coagulation Time | 2007 |
The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro.
Topics: Blood Platelets; Cell Line; Cytoprotection; Densitometry; Dose-Response Relationship, Drug; Endothelial Cells; Erythrocytes; Flow Cytometry; Hemolysis; Humans; Lidocaine; Polidocanol; Polyethylene Glycols; Procaine; Protamines; Sclerosing Solutions; Serum Albumin, Bovine; Sodium Tetradecyl Sulfate; Transport Vesicles | 2008 |
[The Troyanov-Trendelenburg operation in combination with sclerotherapy as an effective method of outpatient treatment of varicose disease].
Topics: Ambulatory Care; Endothelium, Vascular; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Outpatients; Photomicrography; Polidocanol; Polyethylene Glycols; Retrospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Time Factors; Treatment Outcome; Varicose Veins; Vascular Surgical Procedures; Veins | 2007 |
In vitro effects of detergent sclerosants on antithrombotic mechanisms.
Topics: Anticoagulants; Antithrombins; Blood Coagulation; Detergents; Dose-Response Relationship, Drug; Enoxaparin; Factor Xa; Heparin; Humans; Partial Thromboplastin Time; Polidocanol; Polyethylene Glycols; Protein C; Protein S; Prothrombin; Prothrombin Time; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Thrombosis | 2009 |
More on hypertrichosis after sclerotherapy.
Topics: Humans; Hypertrichosis; Polidocanol; Polyethylene Glycols; Risk Factors; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate | 2010 |
In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors.
Topics: alpha-2-Antiplasmin; Carboxypeptidase B2; Detergents; Fibrinolysis; Humans; Plasma; Plasminogen; Plasminogen Activator Inhibitor 1; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Tissue Plasminogen Activator | 2010 |
In vitro effects of detergent sclerosants on clot formation and fibrinolysis.
Topics: Artifacts; Blood Coagulation; Detergents; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Factor XIII; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Kinetics; Nephelometry and Turbidimetry; Polidocanol; Polyethylene Glycols; Reproducibility of Results; Rotation; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Thrombelastography; Tissue Plasminogen Activator | 2011 |
Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
Topics: Drug Stability; Endothelial Cells; Half-Life; Humans; In Vitro Techniques; Polidocanol; Polyethylene Glycols; Saphenous Vein; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Time Factors; Tunica Media | 2012 |
Low concentration detergent sclerosants induce platelet activation but inhibit aggregation due to suppression of GPIIb/IIIa activation in vitro.
Topics: Cells, Cultured; Detergents; Dose-Response Relationship, Drug; Humans; Platelet Activation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2012 |
Significant endothelin release in patients treated with foam sclerotherapy.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Endothelin-1; Gases; Humans; Polidocanol; Polyethylene Glycols; Rats; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Varicose Veins | 2012 |
European guidelines for sclerotherapy in chronic venous disorders.
Topics: Chronic Disease; Europe; Female; Humans; Male; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Societies, Medical; Sodium Tetradecyl Sulfate; Varicose Veins | 2014 |
Sclerosant foam structure and stability is strongly influenced by liquid air fraction.
Topics: Air; Injections, Intravenous; Microbubbles; Models, Anatomic; Models, Cardiovascular; Molecular Conformation; Polidocanol; Polyethylene Glycols; Polyvinyl Chloride; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Time Factors | 2013 |
Foam sclerosants are more stable at lower temperatures.
Topics: Cold Temperature; Dosage Forms; Drug Stability; Half-Life; Hot Temperature; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Surface Tension; Temperature; Time Factors | 2013 |
Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Comorbidity; Female; Humans; Injections, Intravenous; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polidocanol; Polyethylene Glycols; Recurrence; Retrospective Studies; Risk Factors; Sclerosing Solutions; Sclerotherapy; Sex Factors; Sodium Tetradecyl Sulfate; Time Factors; Treatment Outcome; Ultrasonography, Interventional; Varicose Ulcer; Venous Thrombosis; Warfarin; Wound Healing; Young Adult | 2014 |
Discussion.
Topics: Female; Humans; Male; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Varicose Ulcer; Venous Thrombosis; Wound Healing | 2014 |
Basic physiochemical and rheological properties of detergent sclerosants.
Topics: Air; Detergents; Micelles; Polidocanol; Polyethylene Glycols; Rheology; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Surface Tension | 2015 |
An analysis of 72% chromated glycerin used for sclerotherapy: sterility, potency, and cost after extended shelf life.
Topics: Chromates; Colony Count, Microbial; Costs and Cost Analysis; Drug Storage; Endotoxins; Glycerol; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Sterilization; Time Factors | 2015 |
Detergent sclerosants are deactivated and consumed by circulating blood cells.
Topics: Blood Cells; Blood Coagulation; Cells, Cultured; Detergents; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Polidocanol; Polyethylene Glycols; Sodium Tetradecyl Sulfate | 2015 |
Complications of sclerotherapy for 75 head and neck venous malformations.
Topics: Adult; Female; Finland; Head; Humans; Male; Neck; Polidocanol; Polyethylene Glycols; Retrospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Treatment Outcome; Vascular Malformations; Veins | 2016 |
Detergent Sclerosants Stimulate Leukocyte Apoptosis and Oncosis.
Topics: Apoptosis; Caspases; Detergents; Humans; Leukocytes; Necrosis; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2016 |
Generation of sclerosant foams by mechanical methods increases the foam temperature.
Topics: Cold Temperature; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Temperature | 2017 |
Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Topics: Cohort Studies; Endothelial Cells; Female; Humans; Hyperpigmentation; Inflammation; Leg; Middle Aged; Muscle, Smooth; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Telangiectasis; Veins | 2017 |
Response to Professor Whitely, concerning "Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation".
Topics: Humans; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Telangiectasis | 2018 |
Letter Re: Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
Topics: Humans; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Telangiectasis | 2018 |
Safety Profile of Sclerosing Agents: An Analysis From the World Health Organization Pharmacovigilance Database VigiBase.
Topics: Adverse Drug Reaction Reporting Systems; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Ethanolamine; Humans; Pharmacovigilance; Polidocanol; Risk Assessment; Sclerosing Solutions; Sodium Tetradecyl Sulfate; Telangiectasis; Varicose Veins; Vascular Malformations; World Health Organization | 2019 |
Circulating blood cells influence the fibrinolytic capacity of clots generated in the presence of detergent sclerosants.
Topics: Detergents; Fibrinolysis; Humans; Male; Polidocanol; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2020 |
Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Databases, Factual; Female; Humans; Infant; Infant, Newborn; Male; Polidocanol; Regional Blood Flow; Retrospective Studies; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Time Factors; Treatment Outcome; Vascular Malformations | 2020 |
The effect of the calibre and length of needle on the stability of sclerosing foam.
Topics: Humans; Needles; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate | 2021 |
Foam bubble size is significantly influenced by sclerosant concentration for polidocanol but not sodium tetradecyl sulphate.
Topics: Humans; Polidocanol; Sclerosing Solutions; Sodium Tetradecyl Sulfate | 2021 |
LIPIODOL reduces the lytic activity of detergent sclerosants
Topics: Detergents; Ethiodized Oil; Polidocanol; Polyethylene Glycols; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate | 2021 |
Inframalleolar access in endovenous treatment of venous ulcers and C5 disease with nonthermal nontumescent techniques.
Topics: Aged; Endovascular Procedures; Female; Humans; Male; Middle Aged; Polidocanol; Recurrence; Retrospective Studies; Saphenous Vein; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; Time Factors; Treatment Outcome; Varicose Ulcer; Venous Insufficiency; Wound Healing | 2022 |
Intracavitary Foam Sclerotherapy in Dissecting Cellulitis of the Scalp.
Topics: Adult; Cellulitis; Humans; Male; Middle Aged; Polidocanol; Scalp Dermatoses; Sclerosing Solutions; Sclerotherapy; Skin Diseases, Genetic; Sodium Tetradecyl Sulfate | 2021 |
Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration.
Topics: Humans; Polidocanol; Sclerosing Solutions; Sclerotherapy; Sodium Tetradecyl Sulfate; United States; United States Food and Drug Administration | 2022 |